Clinically, individuals with a longer duration of diabetes, those living with obesity (BMI ≥30), patients dependent on insulin therapy, and those with comorbid conditions like hypertension and dyslipidemia were more likely to exhibit poor glycemic control. This evidence concerns the gene INS and obesity disorder.